Yang, Sen
Zhao, Huaxin
Zhang, Hanzhi
Wang, Junpeng
Jin, Hua
Stirling, Kyle
Ge, Xuhua
Ma, Le
Pu, Zhen
Niu, Xiaomin
Yu, Dehua
Funding for this research was provided by:
Scientific Research Project of Shanghai Municipal Health Commission (20234Y0057)
National Natural Science Foundation of China (72104183)
Projects of the Committee of Shanghai Science and Technology (20Y11913700)
Shanghai Municipal Medical and Health Outstanding Academic Leader Program (GWVI-11.2-XD40)
Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2017B030314120)
Beijing CSCO (Sisco) Clinical Oncology Research Grant (Y-HS202101-0205)
Article History
Received: 4 July 2023
Accepted: 7 February 2024
First Online: 8 March 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Yangpu Hospital affiliated with Tongji University’s Institutional Review Board (No. of ethics approval: LL-2022-LW-007). All study participants provided informed consent to participate in the study.
: Not applicable.
: The authors declare no competing interests.